Skip to main content
Erschienen in: Hereditary Cancer in Clinical Practice 1/2013

Open Access 01.12.2013 | Research

Sense of coherence and self-concept in Lynch syndrome

verfasst von: Helle Vendel Petersen, Steen Ladelund, Christina Carlsson, Mef Nilbert

Erschienen in: Hereditary Cancer in Clinical Practice | Ausgabe 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Objective

Most individuals who learn about hereditary cancer manage well, but identification of subgroups who find this knowledge burdening would allow psychosocial intervention. The objective of the study was to assess sense of coherence (SOC) in individuals with Lynch syndrome with comparison to a general population and correlation to self-concept.

Methods

A total of 345 individuals with Lynch syndrome completed the 13-item SOC scale and the 20-item Lynch syndrome self-concept scale. SOC scores were compared to a general Danish population and were correlated to self-concept estimates in individuals with Lynch syndrome. Characteristics of subgroups with adverse scores were described.

Results

Individuals with Lynch syndrome reported SOC scores similar to the general population. SOC and self-concept correlated well with a correlation coefficient of −0.51. Subsets with convergent and divergent scores, which may reflect different effects from knowledge about hereditary cancer, were identified.

Conclusion

Individuals with Lynch syndrome report SOC scores similar to the general population. SOC and self-concept correlate well but allow identification of subset who report adverse outcome and may be relevant for targeted intervention.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1897-4287-11-7) contains supplementary material, which is available to authorized users.

Competing interests

The authors have declared that there is no conflict of interest.

Authors’ contributions

HVP designed the study, collected data and drafted the manuscript. SL participated in study design, performed statistical analyses and contributed to the manuscript. CC contributed to study design and the manuscript. MN contributed to study design, supported the project financially and contributed to the manuscript. All authors read and approved of the final manuscript.

Introduction

Genetic diagnostics is available for an increasing number of hereditary syndromes, which implies that a growing number of families live with knowledge about hereditary cancer. Lynch syndrome is a multi-cancer syndrome caused by inherited DNA mismatch-repair gene mutations that confer particularly high risks for colorectal cancer and gynaecological cancer. Genetic counselling provides information about the trait, possibilities for genetic testing and recommendations for cancer-preventive surveillance programs. In Lynch syndrome, genetic diagnostics is requested by most family members at risk, and is beneficial since colonoscopic surveillance effectively reduces morbidity and mortality from colorectal cancer[15].
Individuals in families with hereditary cancer have often experienced death from cancer in close relatives and can be hypothesized to be burdened from these experiences[6]. Studies that have addressed the psychological well-being in individuals at increased risk of cancer have primarily focused on the time around genetic counselling and have in the majority of individuals demonstrated temporarily increased levels of distress and anxiety with return to base-line 6–12 months after genetic testing[710]. A subset of 5-10% of the individuals, however, report persistent distress related to their test result[9, 11, 12]. A history of psychosocial problems or depression has been found to correlate with increased anxiety and distress after genetic testing[1214]. Also, coping style, external and internal factors such as personal resources, risk perception, social networks, interaction with health care providers and access to psychosocial support have been found to influence the ability to handle knowledge about an increased risk of cancer[15, 16]. Though few studies have evaluated the long-term consequences of living with a high risk of cancer, a number of issues have been identified as challenging, e.g. risk perception, colonoscopies, informing children and family communication[9, 12, 15, 1720].
We assessed sense of coherence (SOC) and self-concept in carriers of Lynch syndrome. SOC and self-concept are related in that SOC expresses a person’s perceived ability to handle difficult situations, whereas self-concept reflects the impact specific situations or circumstances may have on a person’s self. Perceptions of the self are considered powerful determinants of behaviour. Through an internal system of knowledge structures, experiences constitute the cognitive foundation of purposive thoughts and actions. Self-concept relates to how people think about and evaluate themselves in specific situations[21]. Individuals with a positive self-concept are more apt at enduring stressful situations as opposed to those with a more negative perception of the self[21]. Self-concept scales for different types of hereditary cancer have been developed[16, 2224]. The Lynch syndrome self-concept scale contains two subscales related to stigma and vulnerability and to gastrointestinal-related anxiety. The scale has shown high convergent validity and promising psychometric characteristics in Western populations[2426]. SOC represents a global estimate of how individuals perceive and handle difficult situations and is based on the three nuclear components comprehensibility, manageability and meaningfulness[2729]. The SOC scale has been validated in different subgroups with satisfactory performance[2931]. SOC is positively correlated to mental health and strong SOC has been found to correlate with low depressive mode, high self-esteem and an optimistic life orientation[27, 3234]. Individuals with strong SOC are estimated to react more appropriately to stressful situations by using relevant personal coping strategies. Women diagnosed with breast cancer, who reported strong SOC, experience fewer stressful events and reported better health status[35, 36]. Consequently, weak SOC has been shown to correlate with anxiety and depression[31, 37]. We aimed to determine SOC in the Lynch syndrome population with comparison to the general population and to correlate SOC and self-concept in individuals with Lynch syndrome.

Method

We used the national Danish hereditary nonpolyposis colorectal cancer (HNPCC) register to identify Lynch syndrome mutation carriers. Data on SOC and self-concept were collected at two occasions; from 200 individuals with verified mutations for Lynch syndrome in Western Denmark in 2009 (as part of a nation-wide self-concept study[26]) and from 145 recently identified mutation carriers (data not previously presented).
The Lynch syndrome self-concept scale contains 20 statements related to gastrointestinal anxiety and stigma-vulnerability with scores ranging from 20–140 on the total scale and from 5–35 and 15–105 on the bowel symptom-related anxiety subscale and the stigma and vulnerability subscale respectively. The lower scores, the less impact on self-concept[24]. SOC was assessed using the 13-item scale with scores ranging from 13–91 with higher scores representing stronger SOC[2830, 34]. Aggregated SOC results from a general Danish population collected within the Danish Longitudinal Health Behaviour study in 1994 were used for comparison[38].
We used the same cut-off values for weak (<63), under average (63–73), over average (74–79) and strong (> 79) in the Lynch syndrome cohort as in the general population to allow for direct comparison. Matching age groups were generated with 7 Lynch syndrome groups with age group 1 (age <25, n = 14), age group 2 (age 25–34, n = 58), age group 3 (age 35–49, n = 197), age group 4 (age 50–59, n = 75), age group 5 (age 60 –69, n = 49), age group 6 (age 70 –79, n = 22) and age group 7 (age >80, n = 5, data not shown due to the low number of individuals). The data from the general-population consisted of the 5 age cohorts born 1975 (n = 663), 1965 (n = 563), 1940 (n = 272), 1930 (n = 270) and 1920 (n = 438). Mean age in the general population was 48 years and 52% were women. Data from men and women were pooled and converted into percentages for comparison. Response categories in the self-concept scale range from 1 = strongly disagree, 4 = neither agree nor disagree to 7 = strongly agree. A mean score of 5 on each item can be considered a negative impact on self-concept and we consequently chose a score of 20x5 = 100 and above as cut-off value for high impact on self-concept.
According to the Danish ethical regulation, ethical approval for this study was not needed.

Statistical analyses

Data analysis was conducted using SAS 9.2 and descriptive statistics was used to summarize Lynch syndrome characteristics with continuous data presented as mean values and standard deviations and discrete data presented as counts and percentages. Univariate analyses were used to explore differences between clinical subsets followed by multivariate linear regression analysis. In the Lynch syndrome cohort the distribution of quartile SOC scores were stratified for age groups, similar to data from the reference population and comparison was made using Fisher’s exact test. This test was also used to compare differences between high and low impact on self-concept including the stratified analysis. Correlations between SOC and self-concept, for the total scale as well as for the sub-scales, used scatter plots and assessment with Pearson correlation coefficient. Student’s t-test was used for comparison of mean values in the two groups.

Results

The overall response rate was 80%. Data on both SOC and self-concept were available from 339/345 (98%) informants. The informants had a mean age of 48 years, ranging from 18 to 87 years and included 175 (51%) women and 139 (40%) individuals with a previous diagnosis of cancer. The mean self-concept score was 55 (SD 22.5) ranging from 20–132. The mean SOC value in the Lynch syndrome subset was 70 (SD12) compared to 65 (SD 11) in the general Danish population[38] (p < 0.0001). When the cut-off values (<63/63-73/73-79/> 79) for SOC were applied to the Lynch syndrome cohort, 16% of the mutation carriers reported weak SOC scores, 21% under average, 22% over average and 40% reported high SOC scores. Univariate analyses did not reveal any differences in SOC scores in relation to sex (p = 0.41). Individuals with previous cancer had somewhat higher scores (mean 71 versus 68) (p = 0.047), but this finding was not significant in multivariate analysis adjusting for sex and age (p = 0.3). The distribution of SOC scores in the Lynch syndrome cohort was similar to the general population. Though SOC increased with age in the reference group as well as in the Lynch syndrome cohort, the effect was more pronounced (Pearson correlation coefficient 0.2) among older individuals with Lynch syndrome who reported significantly higher SOC scores (Figure 1).
SOC and self-concept were correlated, i.e. strong SOC correlated with low impact on self-concept (Pearson correlation coefficient −0.51, p < 0.0001) (Figure 2a). When the SOC scores were correlated to the self-concept subscales, the stigma and vulnerability subscale showed a pattern similar to the total self-concept scale (correlation coefficient −0.54, p < 0.0001), whereas the correlation between SOC and the subscale for bowel symptom-related anxiety was weaker (correlation coefficient - 0.3, p < 0.001) (Figure 2b). In total 4% of the individuals reported high impact on the total self-concept scale, whereas 23% reported high impact on the bowel symptom-related anxiety subscale. Among individuals with weak SOC, high impact on total self-concept was reported by 14% and when the bowel symptom-related anxiety subscale was considered, by 38% (Table 1). When self-concept data were stratified for sex, previous cancer and experiences from cancer in close relatives, women and individuals with experience reported significantly higher scores on the bowel significantly higher scores on the bowel symptom-related subscale.
Table 1
Distribution of SOC and self-concept scores
 
Low impact on
High impact on
 
 
self-concept,N (%)
self-concept,N (%)
P value
Strong SOC
253 (99.6)
1 (0.4)
<0.0001
Weak SOC
73 (85.9)
12 (14.1)
 
 
Stigma and vulnerability subscale
 
Strong SOC
254 (100)
0 (0)
<0.0001
Weak SOC
75 (88.2)
10 (11.8)
 
 
Bowel symptom-related subscale
 
Strong SOC
208 (81.9)
46 (18.1)
<0.001
Weak SOC
53 (62.4)
32 (37.6)
 

Discussion

Knowledge about how individuals at increased risk of cancer manage life is insufficient, though it would provide an important basis for the development of targeted support. We took advantage of two validated scales, SOC and self-concept, that evaluate different aspects of how individuals handle difficulties and perceive an increased risk of cancer. Whereas SOC represents a more global estimate of how difficult situations are perceived and managed, self-concept relates to the specific impact from hereditary cancer and the need for surveillance. SOC scores in the Lynch syndrome cohort were comparable to those in the general population and in the oldest cohort, mutation carriers indeed reported stronger SOC than age-matched controls (Figure 1). Similar observations, with higher SOC in older individuals at increased risk, have been reported in hereditary breast cancer and in long-term survivors of childhood cancer[39, 40]. SOC generally tends to strengthen with increasing age, especially among individuals with strong SOC[30, 38, 41, 42]. Mutation carriers who have reached high age either represent cancer survivors or individuals who despite a high risk did not develop cancer, which may contribute to a perception of having dealt well with a life at increased risk.
SOC and self-concept scores were clearly correlated. Adverse scores on both scales, i.e. weak SOC and high impact on self-concept were only reported by 4%, though when we applied a relatively high cut-off. The subset with adverse scores on both scales most likely reflects a vulnerable subset that may be in need of more general psychological support, though additional data regarding the relation to health status are needed (27;41). Only a smaller group of individuals reported a high impact on self-concept, which supports the notion that the majority of individuals at increased risk do well. When the bowel symptom-related anxiety subscale was considered, weak SOC and a low impact on self-concept were reported by 17% of the individuals. This subset likely represents individuals, who despite less self-reported ability to handle difficult situations, experience a limited impact from the knowledge about hereditary cancer. In colorectal cancer, low SOC has been found to be associated with anxiety and depression after genetic counselling and have been demonstrated to correlate with mental health and lower quality of life[27, 32]. Long-term cancer survivors who report a need for support have also been found to have lower SOC scores[40]. Hence, individuals with weak SOC may represent a vulnerable subset despite a minor perceived impact on self-concept. A substantial impact on self-concept related to bowel-related anxiety, despite strong SOC, was reported by 14% and likely includes individuals who generally handle difficult situations well, but find knowledge about hereditary cancer particularly burdening.

Conclusion

Lynch syndrome mutation carriers report SOC scores comparable to the general population, which suggests that despite an increased risk of cancer, most individuals find themselves capable of handling difficult situations to the same extent as a reference population. When SOC and self-concept data are correlated, different subsets are recognized, which points to diverging effects from learning about hereditary cancer. Further work is needed to determine clinically relevant cut-off values and to assess predictive value in relation to clinical and psychosocial outcomes but the different subsets identified can indicate a need for diversified interventions.

Acknowledgements

We would like to thank the Danish HNPCC register, in particular Dr. Inge Bernstein, for assistance with data collection and the Danish Lynch syndrome families for generously sharing their experiences. Financial support was granted from the Danish Cancer Society and Copenhagen University Hospital, Hvidovre, Denmark.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors have declared that there is no conflict of interest.

Authors’ contributions

HVP designed the study, collected data and drafted the manuscript. SL participated in study design, performed statistical analyses and contributed to the manuscript. CC contributed to study design and the manuscript. MN contributed to study design, supported the project financially and contributed to the manuscript. All authors read and approved of the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP: Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009,27(28):4793–7. 10.1200/JCO.2009.23.7784CrossRefPubMed Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP: Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009,27(28):4793–7. 10.1200/JCO.2009.23.7784CrossRefPubMed
2.
Zurück zum Zitat Lynch HT, Lynch JF, Lynch PM, Attard T: Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008,7(1):27–39. 10.1007/s10689-007-9165-5CrossRefPubMed Lynch HT, Lynch JF, Lynch PM, Attard T: Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008,7(1):27–39. 10.1007/s10689-007-9165-5CrossRefPubMed
3.
Zurück zum Zitat Lynch PM: Standards of care in diagnosis and testing for hereditary colon cancer. Fam Cancer 2008,7(1):65–72. 10.1007/s10689-007-9159-3CrossRefPubMed Lynch PM: Standards of care in diagnosis and testing for hereditary colon cancer. Fam Cancer 2008,7(1):65–72. 10.1007/s10689-007-9159-3CrossRefPubMed
4.
Zurück zum Zitat Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, et al.: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007,44(6):353–62. 10.1136/jmg.2007.048991CrossRefPubMedPubMedCentral Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, et al.: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007,44(6):353–62. 10.1136/jmg.2007.048991CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, Van KM, et al.: One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010,138(7):2300–6. 10.1053/j.gastro.2010.02.053CrossRefPubMed Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, Van KM, et al.: One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010,138(7):2300–6. 10.1053/j.gastro.2010.02.053CrossRefPubMed
6.
Zurück zum Zitat Andjelic-Dekic N, Tomasevic Z, Milosevic S, Kolarevic D, Jelic S: Do we know how many cancer patients have a family history of cancer? J BUON 2010,15(1):127–30.PubMed Andjelic-Dekic N, Tomasevic Z, Milosevic S, Kolarevic D, Jelic S: Do we know how many cancer patients have a family history of cancer? J BUON 2010,15(1):127–30.PubMed
7.
Zurück zum Zitat Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H: Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001,93(4):608–11. 10.1002/ijc.1372CrossRefPubMed Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H: Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001,93(4):608–11. 10.1002/ijc.1372CrossRefPubMed
8.
Zurück zum Zitat Bjorvatn C, Eide GE, Hanestad BR, Havik OE: Anxiety and depression among subjects attending genetic counseling for hereditary cancer. Patient Educ Couns 2008,71(2):234–43. 10.1016/j.pec.2008.01.008CrossRefPubMed Bjorvatn C, Eide GE, Hanestad BR, Havik OE: Anxiety and depression among subjects attending genetic counseling for hereditary cancer. Patient Educ Couns 2008,71(2):234–43. 10.1016/j.pec.2008.01.008CrossRefPubMed
9.
Zurück zum Zitat Bleiker EM, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LD, et al.: Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hered Cancer Clin Pract 2007,5(2):59–66. 10.1186/1897-4287-5-2-59CrossRefPubMedPubMedCentral Bleiker EM, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LD, et al.: Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hered Cancer Clin Pract 2007,5(2):59–66. 10.1186/1897-4287-5-2-59CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Meiser B: Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005,14(12):1060–74. 10.1002/pon.933CrossRefPubMed Meiser B: Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005,14(12):1060–74. 10.1002/pon.933CrossRefPubMed
11.
Zurück zum Zitat Bleiker EM, Hahn DE, Aaronson NK: Psychosocial issues in cancer genetics–current status and future directions. Acta Oncol 2003,42(4):276–86. 10.1080/02841860310004391CrossRefPubMed Bleiker EM, Hahn DE, Aaronson NK: Psychosocial issues in cancer genetics–current status and future directions. Acta Oncol 2003,42(4):276–86. 10.1080/02841860310004391CrossRefPubMed
12.
Zurück zum Zitat Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, et al.: Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005,23(9):1902–10. 10.1200/JCO.2005.07.102CrossRefPubMed Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, et al.: Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005,23(9):1902–10. 10.1200/JCO.2005.07.102CrossRefPubMed
13.
Zurück zum Zitat Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000,8(10):731–8. 10.1038/sj.ejhg.5200532CrossRefPubMed Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000,8(10):731–8. 10.1038/sj.ejhg.5200532CrossRefPubMed
14.
Zurück zum Zitat Nordin K, Liden A, Hansson M, Rosenquist R, Berglund G: Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet 2002,39(9):689–94. 10.1136/jmg.39.9.689CrossRefPubMedPubMedCentral Nordin K, Liden A, Hansson M, Rosenquist R, Berglund G: Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet 2002,39(9):689–94. 10.1136/jmg.39.9.689CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Bartuma K, Nilbert M, Carlsson C: Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations. Hered Cancer Clin Pract 2012,10(1):6. 10.1186/1897-4287-10-6CrossRefPubMedPubMedCentral Bartuma K, Nilbert M, Carlsson C: Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations. Hered Cancer Clin Pract 2012,10(1):6. 10.1186/1897-4287-10-6CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Watkins KE, Way CY, Fiander JJ, Meadus RJ, Esplen MJ, Green JS, et al.: Lynch syndrome: barriers to and facilitators of screening and disease management. Hered Cancer Clin Pract 2011, 9: 8. 10.1186/1897-4287-9-8CrossRefPubMedPubMedCentral Watkins KE, Way CY, Fiander JJ, Meadus RJ, Esplen MJ, Green JS, et al.: Lynch syndrome: barriers to and facilitators of screening and disease management. Hered Cancer Clin Pract 2011, 9: 8. 10.1186/1897-4287-9-8CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Aktan-Collan K, Mecklin JP, Jarvinen H, Nystrom-Lahti M, Peltomaki P, Soderling I, et al.: Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000,89(1):44–50. 10.1002/(SICI)1097-0215(20000120)89:1<44::AID-IJC8>3.0.CO;2-3CrossRefPubMed Aktan-Collan K, Mecklin JP, Jarvinen H, Nystrom-Lahti M, Peltomaki P, Soderling I, et al.: Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000,89(1):44–50. 10.1002/(SICI)1097-0215(20000120)89:1<44::AID-IJC8>3.0.CO;2-3CrossRefPubMed
18.
Zurück zum Zitat McAllister M: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003,64(3):179–89. 10.1034/j.1399-0004.2003.00133.xCrossRefPubMed McAllister M: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003,64(3):179–89. 10.1034/j.1399-0004.2003.00133.xCrossRefPubMed
19.
Zurück zum Zitat McCann S, Macauley D, Barnett Y, Bunting B, Bradley A, Jeffers L, et al.: Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology 2009. McCann S, Macauley D, Barnett Y, Bunting B, Bradley A, Jeffers L, et al.: Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology 2009.
20.
Zurück zum Zitat Palmquist AE, Koehly LM, Peterson SK, Shegog M, Vernon SW, Gritz ER: "The cancer bond": exploring the formation of cancer risk perception in families with Lynch syndrome. J Genet Couns 2010,19(5):473–86. 10.1007/s10897-010-9299-8CrossRefPubMedPubMedCentral Palmquist AE, Koehly LM, Peterson SK, Shegog M, Vernon SW, Gritz ER: "The cancer bond": exploring the formation of cancer risk perception in families with Lynch syndrome. J Genet Couns 2010,19(5):473–86. 10.1007/s10897-010-9299-8CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Markus H, Wurf E: The dynamic self-concept: a social psychological perspective. In Annual rewiew of psychologi Edited by: Rosenweig MR. 1987, 299–337. Markus H, Wurf E: The dynamic self-concept: a social psychological perspective. In Annual rewiew of psychologi Edited by: Rosenweig MR. 1987, 299–337.
22.
Zurück zum Zitat Esplen MJ, Stuckless N, Berk T, Butler K, Gallinger S: The FAP self-concept scale (adult form). Fam Cancer 2009,8(1):39–50. 10.1007/s10689-008-9204-xCrossRefPubMed Esplen MJ, Stuckless N, Berk T, Butler K, Gallinger S: The FAP self-concept scale (adult form). Fam Cancer 2009,8(1):39–50. 10.1007/s10689-008-9204-xCrossRefPubMed
23.
Zurück zum Zitat Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, et al.: The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psychooncology 2009,18(11):1216–29. 10.1002/pon.1498CrossRefPubMed Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, et al.: The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psychooncology 2009,18(11):1216–29. 10.1002/pon.1498CrossRefPubMed
24.
Zurück zum Zitat Esplen MJ, Stuckless N, Wong J, Gallinger S, Aronson M, Rothenmund H, et al.: Development and Validation of an Instrument to Measure the Impact of Genetic Testing on Self-Concept in Lynch Syndrome (LS). Clin Genet 2011,80(5):415–23. 10.1111/j.1399-0004.2011.01770.xCrossRefPubMedPubMedCentral Esplen MJ, Stuckless N, Wong J, Gallinger S, Aronson M, Rothenmund H, et al.: Development and Validation of an Instrument to Measure the Impact of Genetic Testing on Self-Concept in Lynch Syndrome (LS). Clin Genet 2011,80(5):415–23. 10.1111/j.1399-0004.2011.01770.xCrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Petersen HV, Domanska K, Bendahl PO, Wong J, Carlsson C, Bernstein I, et al.: Validation of a self-concept scale for lynch syndrome in different nationalities. J Genet Couns 2011,20(3):308–13. 10.1007/s10897-011-9349-xCrossRefPubMed Petersen HV, Domanska K, Bendahl PO, Wong J, Carlsson C, Bernstein I, et al.: Validation of a self-concept scale for lynch syndrome in different nationalities. J Genet Couns 2011,20(3):308–13. 10.1007/s10897-011-9349-xCrossRefPubMed
26.
Zurück zum Zitat Petersen HV, Esplen MJ, Ladelund S, Bernstein I, Sunde L, Carlsson C, et al.: Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study. Fam Cancer 2011,10(4):633–9. 10.1007/s10689-011-9459-5CrossRefPubMed Petersen HV, Esplen MJ, Ladelund S, Bernstein I, Sunde L, Carlsson C, et al.: Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study. Fam Cancer 2011,10(4):633–9. 10.1007/s10689-011-9459-5CrossRefPubMed
27.
Zurück zum Zitat Eriksson M, Lindstrom B: Antonovsky's sense of coherence scale and the relation with health: a systematic review. J Epidemiol Community Health 2006,60(5):376–81. 10.1136/jech.2005.041616CrossRefPubMedPubMedCentral Eriksson M, Lindstrom B: Antonovsky's sense of coherence scale and the relation with health: a systematic review. J Epidemiol Community Health 2006,60(5):376–81. 10.1136/jech.2005.041616CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Antonovsky A: Unravelling the mystery of health. How people manage stress and stay well. San Francisco: Jossey-Bass; 1987. Antonovsky A: Unravelling the mystery of health. How people manage stress and stay well. San Francisco: Jossey-Bass; 1987.
29.
Zurück zum Zitat Antonovsky A: The structure and properties of the sense of coherence scale. Soc Sci Med 1993,36(6):725–33. 10.1016/0277-9536(93)90033-ZCrossRefPubMed Antonovsky A: The structure and properties of the sense of coherence scale. Soc Sci Med 1993,36(6):725–33. 10.1016/0277-9536(93)90033-ZCrossRefPubMed
30.
Zurück zum Zitat Eriksson M, Lindstrom B: Validity of Antonovsky's sense of coherence scale: a systematic review. J Epidemiol Community Health 2005,59(6):460–6. 10.1136/jech.2003.018085CrossRefPubMedPubMedCentral Eriksson M, Lindstrom B: Validity of Antonovsky's sense of coherence scale: a systematic review. J Epidemiol Community Health 2005,59(6):460–6. 10.1136/jech.2003.018085CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Siglen E, Bjorvatn C, Engebretsen LF, Berglund G, Natvig GK: The influence of cancer-related distress and sense of coherence on anxiety and depression in patients with hereditary cancer: a study of patients' sense of coherence 6 months after genetic counseling. J Genet Couns 2007,16(5):607–15. 10.1007/s10897-007-9095-2CrossRefPubMed Siglen E, Bjorvatn C, Engebretsen LF, Berglund G, Natvig GK: The influence of cancer-related distress and sense of coherence on anxiety and depression in patients with hereditary cancer: a study of patients' sense of coherence 6 months after genetic counseling. J Genet Couns 2007,16(5):607–15. 10.1007/s10897-007-9095-2CrossRefPubMed
32.
Zurück zum Zitat Eriksson M, Lindstrom B: Antonovsky's sense of coherence scale and its relation with quality of life: a systematic review. J Epidemiol Community Health 2007,61(11):938–44. 10.1136/jech.2006.056028CrossRefPubMedPubMedCentral Eriksson M, Lindstrom B: Antonovsky's sense of coherence scale and its relation with quality of life: a systematic review. J Epidemiol Community Health 2007,61(11):938–44. 10.1136/jech.2006.056028CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Idler EL, Benyamini Y: Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997,38(1):21–37. 10.2307/2955359CrossRefPubMed Idler EL, Benyamini Y: Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997,38(1):21–37. 10.2307/2955359CrossRefPubMed
34.
Zurück zum Zitat Feldt T, Lintula H, Suominen S, Koskenvuo M, Vahtera J, Kivimaki M: Structural validity and temporal stability of the 13-item sense of coherence scale: prospective evidence from the population-based HeSSup study. Qual Life Res 2007,16(3):483–93. 10.1007/s11136-006-9130-zCrossRefPubMed Feldt T, Lintula H, Suominen S, Koskenvuo M, Vahtera J, Kivimaki M: Structural validity and temporal stability of the 13-item sense of coherence scale: prospective evidence from the population-based HeSSup study. Qual Life Res 2007,16(3):483–93. 10.1007/s11136-006-9130-zCrossRefPubMed
35.
Zurück zum Zitat Gilbar O: Do attitude toward cancer, sense of coherence and family high risk predict more psychological distress in women referred for a breast cancer examination? Women Health 2003,38(2):35–46. 10.1300/J013v38n02_03CrossRefPubMed Gilbar O: Do attitude toward cancer, sense of coherence and family high risk predict more psychological distress in women referred for a breast cancer examination? Women Health 2003,38(2):35–46. 10.1300/J013v38n02_03CrossRefPubMed
36.
Zurück zum Zitat Kenne SE, Browall M, Persson LO, Fall-Dickson J, Gaston-Johansson F: Relationship of sense of coherence to stressful events, coping strategies, health status, and quality of life in women with breast cancer. Psychooncology 2011, 22: 20--27. Kenne SE, Browall M, Persson LO, Fall-Dickson J, Gaston-Johansson F: Relationship of sense of coherence to stressful events, coping strategies, health status, and quality of life in women with breast cancer. Psychooncology 2011, 22: 20--27.
37.
Zurück zum Zitat Stankunas M, Kalediene R, Starkuviene S: Sense of coherence and its associations with psychosocial health: results of survey of the unemployed in Kaunas. Medicina (Kaunas) 2009,45(10):807–13. Stankunas M, Kalediene R, Starkuviene S: Sense of coherence and its associations with psychosocial health: results of survey of the unemployed in Kaunas. Medicina (Kaunas) 2009,45(10):807–13.
38.
Zurück zum Zitat Due EP, Holstein BE: "Sense of coherence", social class and health in a Danish population study]. Ugeskr Laeger 1998,160(51):7424–9.PubMed Due EP, Holstein BE: "Sense of coherence", social class and health in a Danish population study]. Ugeskr Laeger 1998,160(51):7424–9.PubMed
39.
Zurück zum Zitat Gilbar O: Coping with threat. Implications for women with a family history of breast cancer. Psychosomatics 1998,39(4):329–39. 10.1016/S0033-3182(98)71321-0CrossRefPubMed Gilbar O: Coping with threat. Implications for women with a family history of breast cancer. Psychosomatics 1998,39(4):329–39. 10.1016/S0033-3182(98)71321-0CrossRefPubMed
40.
Zurück zum Zitat Sundberg KK, Lampic C, Arvidson J, Wettergren L: Sense of coherence and need for support among long-term survivors of childhood cancer. Cancer Nurs 2011. Sundberg KK, Lampic C, Arvidson J, Wettergren L: Sense of coherence and need for support among long-term survivors of childhood cancer. Cancer Nurs 2011.
42.
Zurück zum Zitat Nilsson KW, Leppert J, Simonsson B, Starrin B: Sense of coherence and psychological well-being: improvement with age. J Epidemiol Community Health 2010,64(4):347–52. 10.1136/jech.2008.081174CrossRefPubMed Nilsson KW, Leppert J, Simonsson B, Starrin B: Sense of coherence and psychological well-being: improvement with age. J Epidemiol Community Health 2010,64(4):347–52. 10.1136/jech.2008.081174CrossRefPubMed
Metadaten
Titel
Sense of coherence and self-concept in Lynch syndrome
verfasst von
Helle Vendel Petersen
Steen Ladelund
Christina Carlsson
Mef Nilbert
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Hereditary Cancer in Clinical Practice / Ausgabe 1/2013
Elektronische ISSN: 1897-4287
DOI
https://doi.org/10.1186/1897-4287-11-7

Weitere Artikel der Ausgabe 1/2013

Hereditary Cancer in Clinical Practice 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.